Disclosed herein are compounds pharmaceutical compositions and methods for the treatment of viral infection including RNA viral infection as well as compounds pharmaceutical compositions and methods for modulating the RIG I pathway in a subject and/or in cells. These compounds are isoflavone derivatives typically substituted at the 3 position with an aryl group and at the 7 position with a heterofunctional group.